Prof. Yonghua Yu 于甬华
Chief Physician, Professor
Department of Thoracic Radiation Oncology I, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiotherapy for gastrointestinal, hepatobiliary, pancreatic, urogenital, bone and soft tissue tumors, malignant lymphoma, and other abdominal and pelvic cancers. Integrates radiotherapy with chemotherapy, endocrine, targeted, immunotherapy, and supportive care.
Dr. Yu is Chief Physician and Professor at Shandong Cancer Hospital, leading the Second Radiotherapy Ward. Holds a master’s in oncology and a PhD. Serves as doctoral supervisor at Shandong University and Jinan University. Has published over 130 papers, including more than 20 SCI-indexed articles, and received multiple Shandong Provincial Science and Technology Progress Awards.
Professional roles
- Member, Chinese Medical Association
- Member, Radiotherapy Professional Committee, Chinese Medical Doctor Association
- Member, Liver Cancer Professional Committee, Chinese Medical Doctor Association
- Member, Gastric Cancer Professional Committee, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Yu Yonghua). Papers usually list the name as Yonghua Yu or Yu Y.
Selected publications
27 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- Oxid Med Cell Longev, 2022 (senior author): Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas. PubMed 35915607
- Ann Palliat Med, 2021 (senior author): Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined with apatinib: a case report. PubMed 33545800
- Transl Cancer Res, 2020 (senior author): Primary giant cell malignant fibrous histiocytoma of the lung: a rare case report and literature review. PubMed 35117334
- Cancer Res Treat, 2020 (senior author): Risk Factors for Cognitive Impairment in High-Grade Glioma Patients Treated with Postoperative Radiochemotherapy. PubMed 32019288
- Front Physiol, 2018 (senior author): Comprehensive Analysis of the Association Between the rs1138272 Polymorphism of the GSTP1 Gene and Cancer Susceptibility. PubMed 30740061
- J Cancer Res Ther, 2018 (senior author): A prospective longitudinal evaluation of cognition and depression in postoperative patients with high-grade glioma following radiotherapy and chemotherapy. PubMed 30539844
- Oncol Lett, 2018 (senior author): Use of (18)F-FDG PET/CT to predict short-term outcomes early in the course of chemoradiotherapy in stage III adenocarcinoma of the lung. PubMed 30061935
- J Cancer Res Ther, 2018 (senior author): Using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography to estimate the length of gross tumor and involvement of lymph nodes in esophagogastric junction carcinoma. PubMed 29970673
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion